サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/11/14 | 6,730 | 6,930 | 6,420 | 6,520 | +10 | +0.2% | 1,191,000 |
2018/11/13 | 6,130 | 6,650 | 6,000 | 6,510 | +130 | +2% | 1,538,100 |
2018/11/12 | 7,050 | 7,070 | 6,190 | 6,380 | -500 | -7.3% | 2,255,000 |
2018/11/09 | 6,850 | 7,200 | 6,720 | 6,880 | -270 | -3.8% | 2,177,600 |
2018/11/08 | 7,390 | 7,550 | 6,630 | 7,150 | +60 | +0.8% | 4,117,300 |
2018/11/07 | 5,910 | 7,090 | 5,870 | 7,090 | +1,000 | +16.4% | 5,037,200 |
2018/11/06 | 6,090 | 6,090 | 6,000 | 6,090 | +1,000 | +19.6% | 2,393,600 |
2018/11/05 | 5,090 | 5,090 | 5,090 | 5,090 | +705 | +16.1% | 72,100 |
2018/11/02 | 4,385 | 4,385 | 4,385 | 4,385 | +700 | +19% | 85,700 |
2018/11/01 | 3,640 | 3,760 | 3,610 | 3,685 | +5 | +0.1% | 451,800 |
2018/10/31 | 3,430 | 3,690 | 3,410 | 3,680 | +320 | +9.5% | 571,500 |
2018/10/30 | 3,140 | 3,400 | 3,115 | 3,360 | +175 | +5.5% | 671,700 |
2018/10/29 | 3,480 | 3,525 | 3,150 | 3,185 | -270 | -7.8% | 823,400 |
2018/10/26 | 3,610 | 3,645 | 3,385 | 3,455 | -55 | -1.6% | 573,400 |
2018/10/25 | 3,620 | 3,655 | 3,450 | 3,510 | -240 | -6.4% | 826,200 |
2018/10/24 | 3,905 | 3,935 | 3,700 | 3,750 | -95 | -2.5% | 536,500 |
2018/10/23 | 3,940 | 4,020 | 3,815 | 3,845 | -45 | -1.2% | 824,300 |
2018/10/22 | 3,850 | 3,970 | 3,800 | 3,890 | +100 | +2.6% | 704,800 |
2018/10/19 | 3,740 | 3,805 | 3,675 | 3,790 | +25 | +0.7% | 342,700 |
2018/10/18 | 3,715 | 3,845 | 3,715 | 3,765 | +50 | +1.3% | 533,000 |
2018/10/17 | 3,665 | 3,725 | 3,585 | 3,715 | +120 | +3.3% | 429,500 |
2018/10/16 | 3,695 | 3,725 | 3,565 | 3,595 | -75 | -2% | 390,300 |
2018/10/15 | 3,705 | 3,730 | 3,610 | 3,670 | -35 | -0.9% | 303,700 |
2018/10/12 | 3,535 | 3,725 | 3,510 | 3,705 | +165 | +4.7% | 460,800 |
2018/10/11 | 3,375 | 3,620 | 3,355 | 3,540 | -105 | -2.9% | 711,200 |
2018/10/10 | 3,690 | 3,720 | 3,595 | 3,645 | -45 | -1.2% | 425,000 |
2018/10/09 | 3,610 | 3,745 | 3,530 | 3,690 | +115 | +3.2% | 361,100 |
2018/10/05 | 3,665 | 3,725 | 3,540 | 3,575 | -160 | -4.3% | 697,700 |
2018/10/04 | 3,795 | 3,865 | 3,640 | 3,735 | -90 | -2.4% | 475,300 |
2018/10/03 | 3,655 | 3,855 | 3,640 | 3,825 | +125 | +3.4% | 619,600 |
2018/10/02 | 4,000 | 4,010 | 3,690 | 3,700 | -245 | -6.2% | 1,099,100 |
2018/10/01 | 3,950 | 4,040 | 3,890 | 3,945 | ±0 | ±0% | 586,100 |
2018/09/28 | 4,000 | 4,115 | 3,780 | 3,945 | -55 | -1.4% | 953,500 |
2018/09/27 | 3,865 | 4,135 | 3,845 | 4,000 | +190 | +5% | 1,393,400 |
2018/09/26 | 3,820 | 3,915 | 3,775 | 3,810 | +25 | +0.7% | 623,800 |
2018/09/25 | 3,685 | 3,865 | 3,665 | 3,785 | +105 | +2.9% | 793,700 |
2018/09/21 | 3,695 | 3,770 | 3,630 | 3,680 | +115 | +3.2% | 544,100 |
2018/09/20 | 3,615 | 3,620 | 3,510 | 3,565 | -85 | -2.3% | 575,900 |
2018/09/19 | 3,700 | 3,750 | 3,560 | 3,650 | -145 | -3.8% | 1,013,500 |
2018/09/18 | 3,810 | 3,845 | 3,690 | 3,795 | -120 | -3.1% | 462,200 |
2018/09/14 | 3,780 | 3,995 | 3,630 | 3,915 | +135 | +3.6% | 824,300 |
2018/09/13 | 3,745 | 3,780 | 3,555 | 3,780 | +105 | +2.9% | 428,700 |
2018/09/12 | 4,050 | 4,090 | 3,625 | 3,675 | -305 | -7.7% | 952,700 |
2018/09/11 | 3,925 | 4,030 | 3,835 | 3,980 | +265 | +7.1% | 975,700 |
2018/09/10 | 3,690 | 3,865 | 3,635 | 3,715 | +40 | +1.1% | 529,900 |
2018/09/07 | 3,560 | 3,705 | 3,415 | 3,675 | +65 | +1.8% | 598,600 |
2018/09/06 | 3,630 | 3,725 | 3,490 | 3,610 | -110 | -3% | 530,400 |
2018/09/05 | 3,750 | 3,880 | 3,485 | 3,720 | +25 | +0.7% | 1,161,800 |
2018/09/04 | 4,100 | 4,135 | 3,555 | 3,695 | -560 | -13.2% | 2,395,400 |
2018/09/03 | 4,300 | 4,385 | 4,145 | 4,255 | +135 | +3.3% | 876,100 |
1651~
1700
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム